New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 13, 2012
11:49 EDTQCORQuestcor down 6% following presentation at investor conference
Shares of biopharmaceutical company Questcor Pharmaceuticals (QCOR) slid in mid-morning trading as the company presented at the JMP Securities Healthcare Conference. During the presentation, the company's Chief Scientific Officer discussed the mechanism of action and unique biological and clinical properties of the company's primary product, Acthar Gel. The company also focused on its strategic plan to focus on "the embedded pipeline in Acthar," highlighting its research and development plans. Investors may have been disappointed that the company did not directly speak to allegations recently made by short sellers, specifically the accusations made by Citron Research in a report published July 10. In mid-morning trading, Questcor fell $2.88, or 6.33%, to $42.60 after being up marginally at the open.
News For QCOR From The Last 14 Days
Check below for free stories on QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
10:58 EDTQCORPaulson action positive for Mallinckrodt, Questcor, says BMO Capital
BMO Capital said Paulson & Co. being granted an option to increase its stake in Mallinckrodt (MNK) to 20% will be viewed by the market as a bullish sign and points to the Questcor (QCOR) acquisition likely being completed. BMO also believes Paulson's position could also provide a defense mechanism if a hostile bid were made on Mallinckrodt. The firm maintains an Outperform rating on Mallinckrodt.
09:42 EDTQCORMallinckrodt increases Paulson & Co. threshold to 20% from 10%
Subscribe for More Information
April 21, 2014
09:02 EDTQCORQuestcor's Acthar shows positive results in clinical study
Subscribe for More Information
07:26 EDTQCORQuestcor shares can advance significantly, says Oppenheimer
Subscribe for More Information
06:14 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 17, 2014
09:32 EDTQCORLeerink's specialty pharma/generics analyst has analyst/industry conference call
Subscribe for More Information
03:54 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Stocks with implied volatility below IV index mean; Questcor (QCOR) 47, MannKind (MNKD) 82 according to iVolatility.
April 16, 2014
06:23 EDTQCOR Stocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 15, 2014
07:42 EDTQCORFDA received two documents questioning Acthar, says Jefferies
Subscribe for More Information
06:04 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 14, 2014
05:54 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Stocks with implied volatility below IV index mean; Questcor (QCOR) 44, MannKind (MNKD) 83 according to iVolatility.
April 11, 2014
10:46 EDTQCOROptions with decreasing implied volatility: MNKD QCOR NQ WWE BBBY
06:04 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 10, 2014
11:03 EDTQCOROptions with decreasing implied volatility: MNKD QCOR MU KMX
06:06 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use